| 2024-05-08 | Plus Therapeutics, Inc. PSTV | director | 12,255 0.2576% | $2.04 | $25,000 | -4.85% | ||
| 2023-09-11 | Plus Therapeutics, Inc. PSTV | director | 20,000 0.7886% | $1.70 | $34,062 | +23.67% | ||
| 2023-05-12 | Sale | PROS Holdings, Inc. PRO | director | 2,383 0.0052% | $24.61 | $58,646 | +40.78% | |
| 2022-11-04 | Sale | PROS Holdings, Inc. PRO | director | 6,000 0.0132% | $25.76 | $154,560 | +9.88% | |
| 2022-05-17 | Plus Therapeutics, Inc. PSTV | 30,000 0.0093% | $0.55 | $16,500 | -16.98% | |||
| 2022-05-12 | Sale | PROS Holdings, Inc. PRO | 1,536 0.0035% | $24.91 | $38,262 | +5.78% | ||
| 2021-10-27 | Plus Therapeutics, Inc. PSTV | director | 12,500 0.0063% | $1.72 | $21,500 | -50% | ||
| 2021-04-30 | Sale | PROS Holdings, Inc. PRO | director | 1,684 0.0039% | $43.72 | $73,624 | -17.8% | |
| 2020-08-13 | Plus Therapeutics, Inc. PSTV | director | 10,000 0.0145% | $2.80 | $28,000 | -18.15% | ||
| 2020-08-12 | Plus Therapeutics, Inc. PSTV | director | 10,000 0.0146% | $2.52 | $25,200 | -8.59% | ||
| 2020-06-11 | Aterian, Inc. ATER | director | 2,000 0.0132% | $5.00 | $10,000 | +98.37% | ||
| 2020-06-10 | Aterian, Inc. ATER | director | 5,000 0.034% | $5.65 | $28,250 | +80.02% | ||
| 2020-06-09 | Aterian, Inc. ATER | director | 5,000 0.0334% | $5.47 | $27,350 | +82.2% | ||
| 2020-06-08 | Aterian, Inc. ATER | director | 5,000 0.0326% | $5.35 | $26,750 | +81.2% | ||
| 2020-05-01 | Sale | PROS Holdings, Inc. PRO | director | 581 0.0014% | $33.00 | $19,173 | +33.23% | |
| 2020-01-16 | Sale | PROS Holdings, Inc. PRO | director | 1,743 0.004% | $68.08 | $118,663 | -42.01% | |
| 2010-08-16 | PROS Holdings, Inc. PRO | director | 5,550 0.021% | $7.86 | $43,623 | +50.63% | ||
| 2010-08-13 | PROS Holdings, Inc. PRO | director | 1,750 0.0067% | $7.33 | $12,828 | +62.48% | ||
| 2010-08-12 | PROS Holdings, Inc. PRO | director | 2,700 0.0103% | $6.98 | $18,846 | +71.49% |